DiscoverAdvances in CareCancer Crusader: Challenging the Current State of Gynecologic Cancer
Cancer Crusader: Challenging the Current State of Gynecologic Cancer

Cancer Crusader: Challenging the Current State of Gynecologic Cancer

Update: 2023-05-31
Share

Description

Inspired by her beloved aunt, Dr. Onyinye Balogun began her medical career with a mission in mind: to mitigate the suffering that people with cancer experience over the course of their life-saving treatments. Her approach has been multi-faceted and systematic. After being awarded New York Genome Center’s Polyethnic-1000 grant, Dr Balogun has led the investigation into potential genomic mutations that could be contributing to the disproportionate rates of uterine cancer diagnoses in Black women. Meanwhile, Dr. Balogun is also partnering with her former patient to update the outmoded and painful brachytherapy devices used in cervical cancer treatments. 

 

For more information visit nyp.org/Advances

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Cancer Crusader: Challenging the Current State of Gynecologic Cancer

Cancer Crusader: Challenging the Current State of Gynecologic Cancer

Dr. Onyinye Balogun, medicine, research, healthcare, physicians, surgery, surgeons, doctors, medical, Advances in Care, discovery, Weill Cornell Medicine, Cornell Tech, Cornell University, hospital, treatment, clinical trials, innovation, Medical, Specialist, Oncology, Brachytherapy, Mission-Driven Tech, Eve McDavid, radiation therapy, radiation oncology, uterine cancer, cervical cancer, Polyethnic 1000 study, endometrial cancer, genomic cancer research, genetics, new york presbyterian, nyp brooklyn, new york presbyterian brooklyn, nigeria, radiation, cancer care, cancer treatment, gynecologic cancer, learning, NewYork-Presbyterian, Catherine Price